Toledano Miranda Jayne's Form 4 filing
Entera Bio Ltd. (ENTX) · filed Jul 16, 2026
- Accession no.
- 0001178913-26-003508
- Filed
- Jul 16, 2026, 4:05 PM ET
- Trade date
- Jul 14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Toledano Miranda JayneCIK 0001686530 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | AGrant or awardAcquired | +347,567 | $0.00 | $0 | 774,142 | Direct | |
| Jul 14, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | AGrant or awardAcquired | +72,993 | $0.00 | $0 | 847,135 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.